scholarly journals Mutations in GPAA1 , Encoding a GPI Transamidase Complex Protein, Cause Developmental Delay, Epilepsy, Cerebellar Atrophy, and Osteopenia

2017 ◽  
Vol 101 (5) ◽  
pp. 856-865 ◽  
Author(s):  
Thi Tuyet Mai Nguyen ◽  
Yoshiko Murakami ◽  
Eamonn Sheridan ◽  
Sophie Ehresmann ◽  
Justine Rousseau ◽  
...  
2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Maria A. Gandini ◽  
Ivana A. Souza ◽  
Laurent Ferron ◽  
A. Micheil Innes ◽  
Gerald W. Zamponi

AbstractCACNA1A pathogenic variants have been linked to several neurological disorders including familial hemiplegic migraine and cerebellar conditions. More recently, de novo variants have been associated with severe early onset developmental encephalopathies. CACNA1A is highly expressed in the central nervous system and encodes the pore-forming CaVα1 subunit of P/Q-type (Cav2.1) calcium channels. We have previously identified a patient with a de novo missense mutation in CACNA1A (p.Y1384C), characterized by hemiplegic migraine, cerebellar atrophy and developmental delay. The mutation is located at the transmembrane S5 segment of the third domain. Functional analysis in two predominant splice variants of the neuronal Cav2.1 channel showed a significant loss of function in current density and changes in gating properties. Moreover, Y1384 variants exhibit differential splice variant-specific effects on recovery from inactivation. Finally, structural analysis revealed structural damage caused by the tyrosine substitution and changes in electrostatic potentials.


2020 ◽  
Vol 106 (4) ◽  
pp. 484-495 ◽  
Author(s):  
Thi Tuyet Mai Nguyen ◽  
Yoshiko Murakami ◽  
Sabrina Mobilio ◽  
Marcello Niceta ◽  
Giuseppe Zampino ◽  
...  

Brain ◽  
2020 ◽  
Vol 143 (10) ◽  
pp. e83-e83
Author(s):  
Ahmed K Saad ◽  
Dana Marafi ◽  
Tadahiro Mitani ◽  
Angad Jolly ◽  
Haowei Du ◽  
...  

Neurogenetics ◽  
2013 ◽  
Vol 15 (2) ◽  
pp. 85-92 ◽  
Author(s):  
Chihiro Ohba ◽  
Nobuhiko Okamoto ◽  
Yoshiko Murakami ◽  
Yasuhiro Suzuki ◽  
Yoshinori Tsurusaki ◽  
...  

2020 ◽  
Vol 139 (12) ◽  
pp. 1499-1511 ◽  
Author(s):  
Yongyun Li ◽  
Liu Yang ◽  
Jie Yang ◽  
Jiahao Shi ◽  
Peiwei Chai ◽  
...  

Neurogenetics ◽  
2014 ◽  
Vol 15 (2) ◽  
pp. 93-93
Author(s):  
Chihiro Ohba ◽  
Nobuhiko Okamoto ◽  
Yoshiko Murakami ◽  
Yasuhiro Suzuki ◽  
Yoshinori Tsurusaki ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Miriam Kessi ◽  
Baiyu Chen ◽  
Jing Peng ◽  
Fangling Yan ◽  
Lifen Yang ◽  
...  

Abstract Background Calcium ions are involved in several human cellular processes including corticogenesis, transcription, and synaptogenesis. Nevertheless, the relationship between calcium channelopathies (CCs) and intellectual disability (ID)/global developmental delay (GDD) has been poorly investigated. We hypothesised that CCs play a major role in the development of ID/GDD and that both gain- and loss-of-function variants of calcium channel genes can induce ID/GDD. As a result, we performed a systematic review to investigate the contribution of CCs, potential mechanisms underlying their involvement in ID/GDD, advancements in cell and animal models, treatments, brain anomalies in patients with CCs, and the existing gaps in the knowledge. We performed a systematic search in PubMed, Embase, ClinVar, OMIM, ClinGen, Gene Reviews, DECIPHER and LOVD databases to search for articles/records published before March 2021. The following search strategies were employed: ID and calcium channel, mental retardation and calcium channel, GDD and calcium channel, developmental delay and calcium channel. Main body A total of 59 reports describing 159 cases were found in PubMed, Embase, ClinVar, and LOVD databases. Variations in ten calcium channel genes including CACNA1A, CACNA1C, CACNA1I, CACNA1H, CACNA1D, CACNA2D1, CACNA2D2, CACNA1E, CACNA1F, and CACNA1G were found to be associated with ID/GDD. Most variants exhibited gain-of-function effect. Severe to profound ID/GDD was observed more for the cases with gain-of-function variants as compared to those with loss-of-function. CACNA1E, CACNA1G, CACNA1F, CACNA2D2 and CACNA1A associated with more severe phenotype. Furthermore, 157 copy number variations (CNVs) spanning calcium genes were identified in DECIPHER database. The leading genes included CACNA1C, CACNA1A, and CACNA1E. Overall, the underlying mechanisms included gain- and/ or loss-of-function, alteration in kinetics (activation, inactivation) and dominant-negative effects of truncated forms of alpha1 subunits. Forty of the identified cases featured cerebellar atrophy. We identified only a few cell and animal studies that focused on the mechanisms of ID/GDD in relation to CCs. There is a scarcity of studies on treatment options for ID/GDD both in vivo and in vitro. Conclusion Our results suggest that CCs play a major role in ID/GDD. While both gain- and loss-of-function variants are associated with ID/GDD, the mechanisms underlying their involvement need further scrutiny.


2016 ◽  
Vol 98 (3) ◽  
pp. 562-570 ◽  
Author(s):  
Tamar Harel ◽  
Gozde Yesil ◽  
Yavuz Bayram ◽  
Zeynep Coban-Akdemir ◽  
Wu-Lin Charng ◽  
...  

Author(s):  
Çiğdem Seher Kasapkara ◽  
Ahmet Cevdet Ceylan ◽  
Hamit Özyürek ◽  
Gülhan Karakaya Molla ◽  
Burcu Civelek Ürey ◽  
...  

Abstract Objectives Congenital disorders of glycosylation (CDGs) are rare inherited metabolic disorders associated with facial dysmorphism and in the majority of the patients, there is an important neurological impairment. Epilepsy was a main concern in rare forms of the disease. There are two groups of the disease: CDG-I results from the defects in glycan addition to the N-terminal and CDG-II occurs due to defects in the processing of protein bound glycans. SLC35A2-CDG is a rare form of CDG caused by mutations in the X-linked gene that encodes a UDP-Galactose transporter. The manifestations of the disease include seizures, failure to thrive, delayed myelination, and cerebral atrophy. Case presentation We describe herein a severe female child with intractable seizures, microcephaly, growth retardation, hypotonia, global developmental delay, facial dysmorphism, skeletal findings, cerebral/cerebellar atrophy, and thin corpus callosum, and a mildly affected male carrying a novel variant with seizures and mild global developmental delay who were found by whole exome sequencing (WES) for SLC35A2 mutations previously not reported. Conclusions Our findings expand the number of reported cases and add novel variants to the repertoire of SLC35A2-CDG.


Sign in / Sign up

Export Citation Format

Share Document